Senior Licensing and Patenting Manager, National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH)
Anna joined the Technology Transfer Office of the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) in January 2011. Dr. Solowiej provides advice to NHGRI scientists about patenting their inventions, negotiates diverse collaboration agreements (such as Clinical Trial Agreements or Cooperative Research and Development Agreements) with academia and industry partners, and markets NHGRI technologies. Anna also negotiates licenses for patented and biological-reagent technologies developed at NHGRI. She is an experienced patent attorney, with expertise in patent prosecution, analysis of portfolios for validity and freedom-to-operate issues, and litigation support.
Anna is also widely engaged with the larger NIH, CDC and FDA technology transfer community, serving on various volunteer work groups, committees, and helping with strategic projects.
Dr. Solowiej is licensed to practice law in Massachusetts, District of Columbia, and before the United States Patent and Trademark Office.
See NHGRI Technology Transfer Office’s website at:http://www.genome.gov/techtransfer
Licensing professionals comprise a diverse category of colleagues managing broad aspects of intellectual property and coordinating strategic alliances. Their career backgrounds include degrees and training in science, medicine, law, business, finance, and others. Many have moved among various career paths, such as university technology offices, law firms, government legal offices, incubators, industry, and/or venture space. […]